DIRS.INFO The most relevant business & tech news

Vaccine makers are depending on the U.S. market as many countries have more limited yearly campaigns for giving updated shots. For BioNTech, Moderna, and Novavax (NVAX.O), COVID vaccines remain their only approved products. Shares of Pfizer were up nearly 5%, however, buoyed by a $3.5 billion cost-cutting plan the drugmaker announced late on Friday alongside its new COVID sales outlook. Moderna, in a statement on Monday, maintained its current revenue forecast of $6 billion to $8 billion for its COVID vaccine for 2023. Jefferies analyst Michael Yee said Pfizer's new COVID outlook implies lower vaccine sales for Moderna than it had forecast.

Persons: Dado, BioNTech, Albert Bourla, Bourla, Mani Foroohar, Foroohar, Jefferies, Michael Yee, Ludwig Burger, Rachel More, Michael Erman, Bhanvi Satija, Manas, Jonathan Oatis, Caroline Humer, Bill Berkrot Organizations: COVID, Institute for Health, Food, REUTERS, Pfizer, Moderna, Manas Mishra, Thomson Locations: Zenica, Bosnia, Herzegovina, Frankfurt, Novavax, U.S, New York, Bengaluru

☆ Pfizer's earnings cut was 'sort of telegraphed', says E Squared's Les Funtleyder
▼ + stars: | 2023-10-16 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPfizer's earnings cut was 'sort of telegraphed', says E Squared's Les FuntleyderLes Funtleyder, E Squared Capital Management healthcare portfolio manager, joins 'Squawk Box' to discuss Pfizer cutting full-year revenue guidance by $9 billion, after the pharmaceutical giant said dwindling demand for Covid-19 vaccines and treatments were responsible for the updated guidance, and more.

Persons: Les Organizations: Squared Capital Management, Pfizer

☆ New RSV protections for infants hit cost, insurance hurdles in U.S. rollout
▼ + stars: | 2023-10-13 | by ( Angelica Peebles | In Angelicapeebles | ) www.cnbc.com time to read: +2 min

Two new immunizations promise to protect babies from respiratory syncytial virus – if people can find them. Providers are scrambling to offer Pfizer's vaccine, Abrysvo, to pregnant patients and Sanofi's monoclonal antibody, Beyfortus, to babies. Until now, the only preventative treatment was another monoclonal antibody called Synagis that's given once a month during RSV season, which generally runs from fall through spring. Sanofi's Beyfortus is a monoclonal antibody that's given directly to babies and provides them with immediate protection. "I know that [RSV]'s a threat to little babies, and so to have an opportunity to prevent illness in the first place is really exciting."

Persons: Michael Chamberlin, hasn't, we're, Chamberlin, that's, Erin Bakke, Graham Organizations: Pediatric Associates Locations: Carmel, Cincinnati , Ohio

☆ US FDA approves Pfizer's inflammatory bowel disease drug
▼ + stars: | 2023-10-13 | by ( ) www.reuters.com time to read: +1 min

REUTERS/Johanna Geron/File Photo Acquire Licensing RightsOct 13 (Reuters) - The U.S. Food and Drug Administration has approved Pfizer's (PFE.N) drug to treat adults with an inflammatory bowel disease called ulcerative colitis, the company said on Friday. The decision was based on data from a late-stage study that showed a reduction in disease symptoms for some patients who took the drug, when compared with the placebo. Globally, the market for inflammatory bowel diseases is about $20 billion, making it a lucrative target for drugmakers. Analysts last year estimated that peak sales for the Pfizer drug could top $3 billion a year. Reporting by Khushi Mandowara in Bengaluru; Editing by Arun Koyyur and Devika SyamnathOur Standards: The Thomson Reuters Trust Principles.

Persons: Johanna Geron, Velsipity, Bristol Myers, Khushi, Arun Koyyur Organizations: Pfizer, REUTERS, U.S . Food, Drug Administration, Arena Pharmaceuticals, Bristol, drugmakers, Thomson Locations: Puurs, Belgium, U.S, United States, Bengaluru

☆ Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump
▼ + stars: | 2023-10-13 | by ( Jacob Pramuk | ) www.cnbc.com time to read: +1 min

Pfizer slashed its full-year earnings and revenue guidance on Friday, as it said demand for its Covid products has waned. The company now expects 2023 sales of $58 billion to $61 billion, down from its previous guidance of $67 billion to $70 billion. Pfizer said it cut its revenue outlook "solely due to its Covid products." The biopharmaceutical company slashed its full-year adjusted earnings guidance to a range of $1.45 to $1.65 per share, from a previous $3.25 to $3.45 per share. It also said it anticipates sales of its vaccine, Comirnaty, will be $2 billion lower than previously expected because of lower-than-expected vaccination rates.

Persons: Albert Bourla Organizations: Pfizer, European Commission, BioNTech, U.S ., CNBC, YouTube Locations: U.S, Puurs, Belgium

REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsLONDON/SHANGHAI Oct 9 (Reuters) - China's largest vaccines company Zhifei (300122.SZ) will pay British drugmaker GSK (GSK.L) 2.5 billion pounds ($3.05 billion pound) for the exclusive rights to distribute GSK's shingles vaccine in the world's No.2 pharmaceuticals market. The deal with Zhifei is part of its efforts to reach more 4 billion pounds ($4.88 billion) in sales by 2026, GSK said. Zhifei will purchase volumes of Shingrix with a value to GSK worth 2.5 billion pounds over an initial three-year period, GSK said. Zhifei shares were up as much as 20% to 58.40 yuan ($8.00) following the filing, their highest point since March 27. Shingrix is currently GSK's biggest product and strongest growth driver, taking in 1.71 billion pounds in first-half sales, up 20% from a year prior.

Persons: Dado Ruvic, Zhifei, Shingrix, Maggie Fick, Andrew Silver, Eva Mathews, Savio D'Souza, Louise Heavens Organizations: GSK, GlaxoSmithKline, REUTERS, British, AstraZeneca, Zhifei, Barclays, Reuters, Thomson Locations: SHANGHAI, China, United States, London, Shanghai, Bengaluru

☆ Alnylam gives up on expanded use of heart-disease drug in US after FDA declines approval
▼ + stars: | 2023-10-09 | by ( Mariam E Sunny | ) www.reuters.com time to read: +2 min

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. The FDA, in 2019, approved Pfizer's (PFE.N) oral drug tafamidis, sold under the brand names Vyndaqel and Vyndamax, to treat transthyretin amyloid cardiomyopathy in the United States. Alnylam said it will focus on another drug candidate, vutrisiran, an under-the-skin injection in late-stage trials to treat ATTR amyloidosis-related cardiomyopathy. Branded as Amvuttra, vutrisiran is also approved in the U.S. to treat nerve damage in adult patients with hereditary ATTR amyloidosis. William Blair analyst Myles Minter estimates peak U.S. sales of $2.2 billion for vutrisiran as an ATTR cardiomyopathy treatment.

Persons: Andrew Kelly, patisiran, ATTR amyloidosis, Alnylam, Luca Issi, ATTR, William Blair, Myles Minter, Mariam Sunny, Pooja Desai Organizations: Food and Drug Administration, FDA, REUTERS, Alnylam Pharmaceuticals, RBC, Thomson Locations: White Oak , Maryland, U.S, Massachusetts, United States, Bengaluru

☆ How 1880s technology made it possible for 2 women to travel around the world in under 80 days
▼ + stars: | 2023-10-07 | by ( Jenny Mcgrath | ) www.businessinsider.com time to read: +19 min

In 1889, journalist Nellie Bly set off on a trip around the world, trying to make it under 80 days. "You see a huge emphasis being placed on building ships that were ever faster than the previous generation of ships," Goodman said. Once aboard the train, Bly began to receive telegrams from her editors and well-wishers. "Sometimes it literally literally just says, 'Nelly Bly's train,'" Behn said. For Behn, what Bly and Bisland did remains incredible and deserve to be remembered as much as Verne's story.

Persons: Nellie Bly, Elizabeth Bisland, —, Jules Verne's, Bly, Bisland, Adrien Behn, Matthew Goodman, Elizabeth Bisland's, Victoria, Augusta Victoria, Henry Guttmann, seasickness, Behn, San Francisco —, Bettmann, Goodman, John Mix Stanley, Said, Getty Images Bly, they'd, Alfred Touchemolin's, voyaged, She'd, James Buchanan, Joseph Pulitzer's, Nelly Bly's, Jules Verne, Thomas Cook, Fogg, Nelly, she'd Organizations: Service, Cosmopolitan, Atlantic, Hulton, Western, Central Pacific, Union Pacific, Union Pacific's Overland, Rockies, Railroad, US, Ships, Suez, Getty Images, Workers, SSPL, Headquarters, Thomas Cook &, Companies Locations: London, New Jersey, New York, California, Blackwell's, of, New York Harbor, Chicago, Omaha, Utah, San, Salt, Union, Iowa, San Francisco, Midwest, Between Nebraska, Sacramento , California, Sierra Nevada, Lake Jessie , North Dakota, Washington ,, Philadelphia, Suez, Europe, Asia, Africa, Britain, India, Port Said, Egypt, Yemen, commonwealths, British, Aden, Colombo, Penang, Hong Kong, Singapore, Ceylon, Yokohama, France, Germany, America, South China, Nevada, Russian Empire, East, North America, London's, Italy, Ireland, United States, Japan, China

☆ GSK raises $1.1 billion from Haleon stake sale
▼ + stars: | 2023-10-06 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Dado Ruvic/Illustration Acquire Licensing RightsOct 6 (Reuters) - British drugmaker GSK (GSK.L) on Friday said it raised 885.6 million pounds ($1.08 billion) from a discounted stake sale in Haleon (HLN.L), cutting its shareholding to 7.4% in the world's largest standalone consumer healthcare firm. The sale of 270 million shares at 328 pence apiece, represented a discount of about 2.5% to Haleon's last close of 336.25 pence on Thursday. Shares in Haleon were down 1.2% while GSK was marginally up 0.4% at 0800 GMT. Pfizer, which holds a 32% stake in Haleon, said in May it plans to cut its ownership in a "slow and methodical" manner within months. The British drugmaker and Pfizer have agreed to not sell any further Haleon shares for 60 days from the settlement of placing.

Persons: Dado Ruvic, Emma Walmsley, Prerna Bedi, Sonia Cheema, Elaine Hardcastle Organizations: GSK, GlaxoSmithKline, REUTERS, British, AstraZeneca, London Stock Exchange, Pfizer, Thomson Locations: Haleon, British, Bengaluru

☆ US plans shift of Merck COVID treatment to commercial market
▼ + stars: | 2023-10-04 | by ( Michael Erman | ) www.reuters.com time to read: +3 min

A COVID-19 treatment pill, called molnupiravir developed by Merck & Co and Ridgeback Biotherapeutics LP is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS/File photo Acquire Licensing RightsOct 4 (Reuters) - The U.S. government will stop distributing free doses of Merck & Co's (MRK.N) COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead. Molnupiravir was initially hailed as a potential breakthrough when few treatment options were available but was soon eclipsed by Pfizer's (PFE.N) rival treatment Paxlovid, which had more impressive data. Merck said the study was limited and that it is confident in the clinical profile of the drug. Merck said it would have a patient assistance program for people who cannot afford the drug.

Persons: Ridgeback Biotherapeutics, Molnupiravir, Merck, Michael Erman, Bill Berkrot Organizations: Merck & Co, Merck & Co Inc, Reuters, Merck, Co Inc, REUTERS, U.S, Co's, Administration, Strategic Preparedness, U.S . Department of Health, Human Services, U.S . Food, Drug Administration, Pfizer's, Thomson Locations: U.S, United States

☆ Pfizer restarts production at tornado-hit North Carolina plant, but drug supply will still be affected
▼ + stars: | 2023-09-25 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

In this aerial image, damage is seen at a Pfizer pharmaceutical factory after a tornado hit the facility two days earlier, in Rocky Mount, North Carolina, July 21, 2023. In a statement, Pfizer stressed that it has only made the "first step toward full recovery" of its plant in Rocky Mount, North Carolina. The Rocky Mount plant supplies nearly 8% of all sterile injectable medicines used in U.S. hospitals, including anesthesia, analgesia, therapeutics, anti-infectives and neuromuscular blockers. Pfizer on Monday said it has restarted production of about 13 medicines, which were prioritized based on "patient need and inventory levels." Pfizer said it is also continuing to monitor emergency request orders for certain medicines manufactured at the Rocky Mount plant.

Organizations: Pfizer, American Society of Health Locations: Rocky Mount, North Carolina, U.S

☆ Explainer: What you need to know about RSV and the new vaccines
▼ + stars: | 2023-09-22 | by ( Michael Erman | ) www.reuters.com time to read: +4 min

That Pfizer (PFE.N) shot and one developed by GSK (GSK.L) in May became the first two RSV vaccines to win U.S. approval, for use in people aged 60 and over to prevent severe illness. Still, infants and older adults have a higher risk of developing severe RSV. RSV leads to 58,000 to 80,000 hospitalizations among children under age 5, and 60,000 to 160,000 hospitalizations among adults age 65 and older each year, according to the CDC. Early data suggests that the RSV shots are protective for at least two years, but it is not yet clear how often older adults will need to be revaccinated. Can I get the RSV shot alongside my COVID and flu shots?

Persons: Pfizer's, Synagis, it's, Jeffrey Duchin, you've, Michael Erman, Bhanvi, Caroline Humer, Bill Berkrot Organizations: . Centers for Disease Control, Prevention, Pfizer, GSK, CDC, FDA, Sanofi, AstraZeneca, Infectious Diseases Society of America, CVS, Humana, Thomson Locations: U.S, Aetna, New York, Bengaluru Edtiting

☆ CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
▼ + stars: | 2023-09-22 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Pfizer's vaccine, called Abrysvo, is already approved and available in the U.S. for adults ages 60 and up. The panel's recommendation puts Pfizer's maternal shot on track to reach the public as RSV begins to spread at higher levels. But younger children and older adults are particularly vulnerable to more severe RSV infections. Each year, the virus kills a few hundred children younger than 5, and 6,000 to 10,000 seniors, according to the CDC. RSV also causes around 58,000 to 80,000 hospitalizations among children younger than 5 years old each year, the CDC said.

Persons: Pfizer, Mandy Cohen, Luis Jodar, Pfizer's Abrysvo, Jefferson Jones, Jones Organizations: Disease Control, U.S, Public, CDC, Pfizer, Northern, Drug Administration, FDA, AstraZeneca Locations: U.S, Sanofi

☆ US CDC panel weighs use of Pfizer's maternal RSV vaccine to protect infants
▼ + stars: | 2023-09-22 | by ( ) www.reuters.com time to read: +2 min

[1/3] A child suffering from an RSV infection at the pediatric intensive care unit at the Asklepios Clinic in Sankt Augustin, Germany, December, 6, 2022. RSV is a common respiratory virus that usually causes mild, cold-like symptoms but can also lead to serious illness and hospitalization. It is typically a seasonal illness, starting in the autumn and peaking in the winter in most of the U.S., according to the CDC. An estimated 58,000 to 80,000 children below the age of five years are hospitalized every year due to RSV infection in the U.S., according to government data. However, the agency said the difference did not appear to be statistically significant, thus might have been due to chance.

Persons: Benjamin Westhoff, Sriparna Roy, Bill Berkrot Organizations: Asklepios, REUTERS, Pfizer, GSK, U.S . Centers for Disease Control, Prevention, U.S . Food, Drug Administration, CDC, FDA, Thomson Locations: Sankt Augustin, Germany, U.S, Bengaluru

☆ Ruth Bader Ginsburg died at 87 after serving as a Supreme Court Justice for 27 years. Here's a look at the trailblazer's life and career.
▼ + stars: | 2023-09-18 | by ( Rachel Premack | Lauren Frias | ) www.businessinsider.com time to read: +1 min

Supreme Court Justice Ruth Bader Ginsburg died on September 18, 2020, due to complications from cancer. She was a left-leaning Associate Justice on the Supreme Court for nearly three decades and a pop culture icon. "Today we mourn, but with confidence that future generations will remember Ruth Bader Ginsburg as we knew her — a tireless and resolute champion of justice," Roberts continued. She spent decades as a trailblazer in gender equality law before she became an Associate Justice of the Supreme Court — and a pop culture icon. AdvertisementAdvertisementShe was on the nation's highest court for nearly 30 years, ever since she took her oath on August 10, 1993.

Persons: Ruth Bader Ginsburg, John Roberts, Ginsburg, Roberts, — Organizations: Service, Supreme Court Locations: Wall, Silicon

☆ Cramer's Lightning Round: Tilray is 'too dangerous'
▼ + stars: | 2023-09-18 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Dollar General's year-to-date stock performance. Stock Chart Icon Stock chart icon Tilray's year-to-date stock performance. Stock Chart Icon Stock chart icon Fastly's year-to-date stock performance. Stock Chart Icon Stock chart icon Iridium's year-to-date stock performance. Stock Chart Icon Stock chart icon Pfizer's year-to-date stock performance.

Persons: Jim Cramer's, I'm, It's Organizations: Pfizer

☆ Glossier founder Emily Weiss loved asking job candidates, 'Why do you work?' new book says
▼ + stars: | 2023-09-18 | by ( Jennifer Ortakales Dawkins | ) www.businessinsider.com time to read: +4 min

The beauty brand's founder, Emily Weiss , started the company as an offshoot of her successful beauty blog, Into the Gloss. In " Glossy: Ambition, Beauty, and the Inside Story of Emily Weiss's Glossier ," author Marisa Meltzer interviewed Weiss as well as Glossier employees and former job candidates who described Weiss's hiring tactics. She told Meltzer that there wasn't a right answer but that this question helped her understand what motivated people. AdvertisementAdvertisement"There has to be more to it than just, 'Oh, I need to support my family,'" Weiss told Meltzer. When she replied with a popular company, Weiss told her she hated it.

Persons: Emily Weiss, Marisa Meltzer, Glossier, Weiss, Emily Weiss's Glossier, Meltzer, Weiss, Taco, I'm Organizations: Service, Taco Bell Locations: Wall, Silicon, Glossier

☆ New Vatican letter suggests Pope Pius XII knew about the Holocaust as early as 1942
▼ + stars: | 2023-09-17 | by ( Marta Biino | ) www.businessinsider.com time to read: +3 min

A newly-uncovered Vatican 1942 letter suggests that then-Pope Pius XII likely knew about Nazi genocide. Pope Pius XII had already been scrutinized for his negotiations with Nazi Germany. Pope Pius XII was afraid Hitler would winGalerie Bilderwelt/Getty ImagesThe relationship between Pope Pius XII and Nazi leadership, especially Adolf Hitler, has long been uncovered and brought Pius under scrutiny, suggesting the pontiff was probably aware of Leiber's correspondence with König. "Pius XII was afraid of, certainly in the first years of the war, that the Nazis were going to win. The beatification process for Pius XII, which started in 1967, has been delayed because of his controversial choices during World War II.

Persons: Pope Pius XII, Sera, Pope, Pius, David Kertzer's, Giovanni Coco, Corriere, Robert Leiber, Lothar König, Hitler, Adolf Hitler, Pius XII, Mussolini, David Kertzer Organizations: Nazi, Service, The Guardian, Nazi Jesuit, Galerie, PBS Locations: Nazi Germany, Wall, Silicon, Germany, German, Polish, Rava, Ukraine, Belzec, Nazi, Poland, Auschwitz, Dachau, There's, Europe

☆ EU antitrust regulators set Oct. 19 deadline for Pfizer's Seagen deal
▼ + stars: | 2023-09-15 | by ( ) www.reuters.com time to read: +1 min

Test tubes are seen in front of Seagen logo in this illustration taken June 27, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsCompanies Pfizer Inc FollowSeagen Inc FollowBRUSSELS, Sept 15 (Reuters) - Pfizer's (PFE.N) $43 billion bid for Seagen (SGEN.O) will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on Friday. U.S. pharmaceutical company Pfizer announced the deal, its biggest, in March for Washington-based Seagen, a pioneer of antibody-drug conjugates, which work like "guided missiles" designed to destroy cancer while sparing healthy cells. The European Commission can either clear the deal after a preliminary review or it can start a four-month long investigation if it has serious concerns. Pfizer sought EU antitrust approval on Thursday.

Persons: Dado Ruvic, Foo Yun Chee, Grant McCool Organizations: REUTERS, Pfizer, Washington, European, Thomson

☆ CEOs from Alphabet, Walmart, Pfizer meet White House officials on refugees
▼ + stars: | 2023-09-14 | by ( Jeff Mason | Thomson Reuters | Jeff Mason Is A White House Correspondent For Reuters. He Has Covered The Presidencies Of Barack Obama | ) www.reuters.com time to read: +2 min

REUTERS/Annegret Hilse/File Photo Acquire Licensing RightsCompanies Accenture PLC FollowAirbnb Inc FollowAlphabet Inc Follow Show more companiesWASHINGTON, Sept 14 (Reuters) - Chief executives from a wide array of U.S. companies will meet White House Chief of Staff Jeff Zients on Thursday to discuss refugee resettlement and sponsorship programs, a White House official said. The CEOs will include Alphabet's Sundar Pichai, Walmart's Doug McMillon, Pfizer's Albert Bourla, HP's Enrique Lores and others. They are part of a council of leaders affiliated with Welcome.US, a group dedicated to helping support refugees in the United States. They will meet Zients and other White House officials "to discuss specific ways we can continue to work together to support safe, orderly pathways for people in need of safety to come to the United States, including through refugee resettlement and new, expanded humanitarian sponsorship programs," a White House official told Reuters. The White House, which says it wants to partner with the private sector to build a humane immigration system, worked with Welcome.US to help Afghan refugees coming to the United States after Biden pulled U.S. troops out of Afghanistan in 2021.

Persons: Annegret, Jeff Zients, Alphabet's Sundar Pichai, Doug McMillon, Pfizer's Albert Bourla, HP's Enrique Lores, Richard Dickson, Julie Sweet, David Risher, Hamdi Ulukaya, Mike Sievert, Goldman Sachs, Kathy Hochul, Zients, Biden, Donald Trump, Welcome.US, Jeff Mason, Christian Schmollinger Organizations: Google, Arena, REUTERS, Accenture, White, Welcome.US, Reuters, Lyft, Mobile, Blackstone, Comcast, Meta, Republicans, Democrat, Republican, Biden, Thomson Locations: Berlin, Germany, WASHINGTON, United States, Airbnb, New, New York City, United, Afghanistan

☆ New Covid boosters could reach Americans as soon as Thursday – here's what you need to know
▼ + stars: | 2023-09-13 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +9 min

Brian Cassella | Tribune News Service | Getty ImagesA new round of Covid vaccines is finally here in the U.S. Meanwhile, the FDA is still reviewing a third updated vaccine from Novavax for people ages 12 and up. Here's everything you need to know about the updated Covid vaccines, from where to find them, whether you can get them for free and when to get them. The agency's website outlines more specific guidelines for staying up to date on Covid vaccines, which differ depending on age group and risk level. Kroger Americans will soon be able to use the federal website vaccines.gov to find other locations offering the updated Covid shots, according to a CDC spokesperson.

Persons: Brian Cassella, Covid, Biden, Megan Wallace, they've, Brian Snyder, vaccines.gov, Evelyn Twentyman, Will, Moderna's, Twentyman, Taison Bell, Bell, CDC's Wallace, Wallace Organizations: Pfizer, Tribune, Service, U.S, The, Disease Control, Moderna, Food and Drug Administration, CDC, FDA, Walgreens, CNBC, WALGREENS, CVS Albertsons, Kroger, Manufacturers, CVS, University of Virginia Health, Younger Locations: Chatham , Illinois, U.S, Covid, Somerville , Massachusetts

☆ Tell-all book lifts the lid on troubled beauty brand Glossier
▼ + stars: | 2023-09-12 | by ( Leah Dolan | ) edition.cnn.com time to read: +8 min

Glossier, a direct-to-consumer cosmetics company launched in 2014 by US businesswoman Emily Weiss, pioneered this new aesthetic. At Glossier, beauty marks were celebrated, freckles were lionized and makeup application became as free form as finger painting. Beyoncé, Serena Williams, Michelle Obama and Reese Witherspoon have all been pictured wearing the makeup brand to red carpet events like the Oscars and The Grammys. For Meltzer, the brand fell victim to something that often trips up companies leading the zeitgeist: an evolving landscape. But “Glossy” isn’t just a beauty brand biography — it’s a forensic cross-examination of an era-defining company and how it embodied a moment in wider culture.

Persons: ”, Emily Weiss, freckles, Paloma Elsesser, Glossier, Serena Williams, Michelle Obama, Reese Witherspoon, Lila Moss, Sydney Sweeny, Gigi Hadid, Marisa Meltzer, “, ” Meltzer, Richard Levine, Weiss ’, Meltzer, ” Glossier, Sophia Amoruso, John Sciulli, Weiss, Leandra Medine, Audrey Gelman, Nasty Gal, Manrepeller’s Leandra Medine, ” Audrey Gelman, John Phillips, Selena, Hailey Bieber’s, ” Marisa Meltzer's, Simon, Simon & Schuster, Schuster, Meltzer didn’t, It’s Organizations: CNN, The, Teen Vogue, Getty, Rhode, Simon & Locations: overhiring, New York, Glossier, SoHo , New York

The updated shots are part of a push by public health officials to align the next COVID vaccines more closely with the actual circulating variant of the virus, similar to the way annual flu shots are designed. The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID vaccines made by Pfizer (PFE.N) and its German partner BioNTech SE (22UAy.DE) as well as by Moderna (MRNA.O). CDC Director Mandy Cohen is expected to approve the recommendations issued by the advisers, allowing Americans to get the updated vaccines. The first COVID vaccines in 2020 were monovalent, or single-target vaccines, aimed at the original strain of the virus. They were followed by bivalent COVID vaccine booster shots that targeted both the original and the Omicron strains.

Persons: Emily Elconin, BioNTech, Caitlin Rivers, Mandy Cohen, Rivers, bivalent, Daniel Kuritzkes, Eris, Kuritzkes, Novavax, Bhanvi, Julie Steenhuysen, Will Dunham, Caroline Humer Organizations: REUTERS, U.S . Centers for Disease Control, Prevention, U.S . Food, Drug Administration, Pfizer, Moderna, FDA, Johns Hopkins Center for Health Security, CDC, Omicron, Brigham, Women's Hospital, Vaccine, EG, Thomson Locations: Waterford , Michigan, U.S, United States, Baltimore, Europe, Asia, Boston, Moderna, Bengaluru, Chicago

☆ FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
▼ + stars: | 2023-09-11 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna , putting the shots on track to reach Americans within days as U.S. hospitalizations from the virus rise. The updated vaccines from Pfizer and Moderna won't be available to Americans just yet. The Biden administration said in August that it expects new single-strain vaccines from Pfizer, Moderna and Novavax targeting XBB.1.5 to be available to the public in mid-September. The upcoming arrival of updated vaccines offers some reassurance to Americans as the nation sees an increase in Covid cases and hospitalizations. Bourla and Moderna CEO Stéphane Bancel, in a separate statement, urged Americans to receive their updated Covid shot during the same appointment as their annual flu shot.

Persons: Biden, Pfizer's, Albert Bourla, Stéphane Bancel, hospitalizations Organizations: Pfizer, BioNTech, Peabody Institute Library, Drug Administration, Moderna, FDA, CDC, Covid, EG Locations: Peabody , Massachusetts, U.S

☆ This week’s most overbought stocks in the S&P 500 include several tech companies
▼ + stars: | 2023-09-09 | by ( Pia Singh | ) www.cnbc.com time to read: +4 min

Wall Street is coming off a losing week, with the Nasdaq Composite Index closing 1.9% lower, the S & P 500 falling 1.3% and the Dow Jones Industrials shedding 0.8%. By contrast, here are the most oversold stocks in the S & P 500: Alaska Air Group has the highest projected upside on the list (+60%), continuing last week's trend . Walgreens Boots Alliance is another of the most oversold companies in the S & P 500. Viatris was the most oversold company in the S & P 500 with a 14-day RSI less than 7. Discount retailers Dollar Tree and Dollar General as well as chemical manufacturer FMC are also among the most oversold companies in the S & P 500.

Persons: Dow Jones, Piper, Baker Hughes, Viatris, Pfizer's Upjohn Organizations: Federal Reserve, Nasdaq, CNBC Pro, Technology, Intuit, IBM, Accenture, CNBC, Autodesk, Verisk, Alaska Air Group, Walgreens Boots Alliance, Walgreens, Wall Street, FMC Locations: Seattle, Mylan

Search resuls for: "Zer's"

25 mentions found